New Events


When: 16 October 2019 @ 10:00 am

ESPT Summer School

The Society ESPT

The ESPT wants to extend knowledge and facilitate clinical implementation of Pharmacogenomics (PGx) and Personalised Medicine in Europe. ESPT consists of over 500 members, divided in individual members, research groups, national societies and corporate members. To establish its mission, ESPT aims to:

  • 1) Enhance knowledge of health care professionals on potential and clinical use of pharmacogenomics to improve personal health care;
    2) Inform patients on the value of PGx;
    3) To promote, inform and offer an independent view of PGx and Personalised Medicine to regulators and policy makers;
    4) To be a partner for industry in strategical discussions related to the clinical implementation of PGx;
    5) To offer a platform for researchers in the field of PGx for interaction, exchange of ideas, sharing research outcomes and facilitating formation of relevant research consortia and research  proposals for grant applications.
Read more about ESPT: Organogram, Board and Members…


Connect with us on Twitter


RT @PharmacoJournal'>PharmacoJournal: We are pleased to announce that the @PharmacoJournal'>PharmacoJournal impact factor has risen to 3.196! Congratulations to the authors,…

1 day, 5 hours ago

RT @PharmacoJournal: Two Case Reports and a Systematic Review of the Literature

1 day, 5 hours ago

RT @ABsteward: Very interesting!🔥 #IDTwitter The first report of falsely elevated vancomycin concentrations in a patient NOT receiving van…

1 day, 13 hours ago


Stay Connected

European Society of Pharmacogenomics and Personalised Therapy